These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

661 related articles for article (PubMed ID: 17438147)

  • 1. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
    Finn AV; Joner M; Nakazawa G; Kolodgie F; Newell J; John MC; Gold HK; Virmani R
    Circulation; 2007 May; 115(18):2435-41. PubMed ID: 17438147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.
    Joner M; Finn AV; Farb A; Mont EK; Kolodgie FD; Ladich E; Kutys R; Skorija K; Gold HK; Virmani R
    J Am Coll Cardiol; 2006 Jul; 48(1):193-202. PubMed ID: 16814667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis.
    Bavry AA; Kumbhani DJ; Helton TJ; Bhatt DL
    J Am Coll Cardiol; 2005 Mar; 45(6):941-6. PubMed ID: 15766833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the incidence of late stent thrombosis after implantation of different drug-eluting stents in the real world coronary heart disease patients: three-year follow-up results.
    Chen JL; Gao LJ; Yang YJ; Li JJ; Qiao SB; Xu B; Huang JH; Yao M; Qin XW; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Gao RL
    Chin Med J (Engl); 2010 Apr; 123(7):778-81. PubMed ID: 20497663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
    Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
    Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry.
    Marzocchi A; Saia F; Piovaccari G; Manari A; Aurier E; Benassi A; Cremonesi A; Percoco G; Varani E; Magnavacchi P; Guastaroba P; Grilli R; Maresta A
    Circulation; 2007 Jun; 115(25):3181-8. PubMed ID: 17562952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings.
    Kotani J; Awata M; Nanto S; Uematsu M; Oshima F; Minamiguchi H; Mintz GS; Nagata S
    J Am Coll Cardiol; 2006 May; 47(10):2108-11. PubMed ID: 16697331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of 36 reported cases of late thrombosis in drug-eluting stents placed in coronary arteries.
    Artang R; Dieter RS
    Am J Cardiol; 2007 Apr; 99(8):1039-43. PubMed ID: 17437724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation.
    Takano M; Inami S; Jang IK; Yamamoto M; Murakami D; Seimiya K; Ohba T; Mizuno K
    Am J Cardiol; 2007 Apr; 99(8):1033-8. PubMed ID: 17437723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical and early clinical experience with a biodegradable polymer-based, rapamycin-eluting, Indian drug-eluting coronary stent: the BIO-RAPID study.
    Bhargava B; Karthikeyan G; Shankar PB; Seth S; Singh S; Pr U; Lal AV; Mohanty M
    Indian Heart J; 2008; 60(3):228-32. PubMed ID: 19240312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathology of drug-eluting stents: implications for coronary intervention.
    Finn AV; Nakazawa G; Virmani R
    Indian Heart J; 2007; 59(2 Suppl B):B41-9. PubMed ID: 19153436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Very late bare-metal stent thrombosis. A case report and review of the literature.
    Manjappa N; Agarwal A; Cavusoglu E
    J Invasive Cardiol; 2006 Jul; 18(7):E203-6. PubMed ID: 16816449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-eluting stents and stent thrombosis: a cause for concern?
    Wernick MH; Jeremias A; Carrozza JP
    Coron Artery Dis; 2006 Dec; 17(8):661-5. PubMed ID: 17119373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neointimal coverage on drug-eluting stent struts crossing side-branch vessels using optical coherence tomography.
    Her AY; Lee BK; Shim JM; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Am J Cardiol; 2010 Jun; 105(11):1565-9. PubMed ID: 20494663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable/unstable angina: insights from optical coherence tomography.
    Gonzalo N; Barlis P; Serruys PW; Garcia-Garcia HM; Onuma Y; Ligthart J; Regar E
    JACC Cardiovasc Interv; 2009 May; 2(5):445-52. PubMed ID: 19463469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative healing response after sirolimus- and paclitaxel-eluting stent implantation in a pig model of restenosis.
    Silva GV; Fernandes MR; Madonna R; Clubb F; Oliveira E; Jimenez-Quevedo P; Branco R; Lopez J; Angeli FS; Sanz-Ruiz R; Vaughn WK; Zheng Y; Baimbridge F; Canales J; Cardoso CO; Assad JA; Falotico R; Perin EC
    Catheter Cardiovasc Interv; 2009 May; 73(6):801-8. PubMed ID: 19309735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neointimal coverage of sirolimus-eluting stents 6 months and 12 months after implantation: evaluation by optical coherence tomography.
    Yao ZH; Matsubara T; Inada T; Suzuki Y; Suzuki T
    Chin Med J (Engl); 2008 Mar; 121(6):503-7. PubMed ID: 18364133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes after multilesion percutaneous coronary intervention: comparison between exclusive and selective use of drug-eluting stents.
    Bertrand OF; Faurie B; Larose E; Nguyen CM; Gleeton O; Déry JP; Noël B; Proulx G; Roy L; Costerousse O; De Larochellière R; Rodés-Cabau J
    J Invasive Cardiol; 2008 Mar; 20(3):99-104. PubMed ID: 18316823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Very late thrombosis after drug-eluting stents.
    Feres F; Costa JR; Abizaid A
    Catheter Cardiovasc Interv; 2006 Jul; 68(1):83-8. PubMed ID: 16763989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of drug-eluting stents including the economic impact of late stent thrombosis.
    Filion KB; Roy AM; Baboushkin T; Rinfret S; Eisenberg MJ
    Am J Cardiol; 2009 Feb; 103(3):338-44. PubMed ID: 19166686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.